Identification and Evaluation of Coronavirus Replicase Inhibitors Using a Replicon Cell Line

Advances in Experimental Medicine and Biology - United States
doi 10.1007/978-0-387-33012-9_111
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer US

Related search

Identification of HCV Inhibitors From a Cell-Based Sub-Genomic Replicon Screen

Open Journal of Medicinal Chemistry
2013English

The Coronavirus Replicase: Insights Into a Sophisticated Enzyme Machinery

Advances in Experimental Medicine and Biology
BiochemistryMedicineGeneticsMolecular Biology
2006English

Viral Replicase Gene Products Suffice for Coronavirus Discontinuous Transcription

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

Identification of HDAC Inhibitors Using a Cell-Based HDAC I/Ii Assay

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2016English

Cell Line‐based Assessment of BTK Inhibitors

British Journal of Pharmacology
Pharmacology
2020English

Economic Evaluation of First Line Treatment for Advanced Non Small Cell Lung Cancer Using Tyrosine Kinase Inhibitors in Malaysia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Identification of Potent and Compartment-Selective Small Molecule Furin Inhibitors Using Cell-Based Assays

Biochemical Pharmacology
BiochemistryPharmacology
2015English

Pharmacoeconomic Evaluation of PD-L1 Receptor Inhibitors for the Second Line Treatment of Metastatic Non-Small Cell Lung Cancer

Medical Technologies. Assessment and Choice
2018English

Evaluation of Defense Strategy Against Influenza a in Cell Line Models

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy